30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Intrinsic Therapeutics Files PMA Application for Barricaid in Lumbar Discectomy -

Intrinsic Therapeutics filed a Premarket Approval application with FDA for the Barricaid® Anular Closure device. The submission was based on 2-year outcomes of 554 trial subjects with a high risk of reherniation, subsequent reoperation and rehospitalization. (Intrinsic Therapeutics, Inc., 12/21/16)